Study of Vitamin D Effect on myoma size
Phase 3
- Conditions
- terine myoma.D25.9Leiomyoma of uterus, unspecified
- Registration Number
- IRCT20160521027998N5
- Lead Sponsor
- Esfahan University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- Female
- Target Recruitment
- 72
Inclusion Criteria
Having 1 to 2 uterine leiomyomas with size 20-80 mm
Serum levels of 25-hydroxyvitamin D3 <20 ngr/ml.
Signed a inform consent form to participate in the study
Exclusion Criteria
Consuming hormonal drugs
Massive vaginal bleeding
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method terine myoma size. Timepoint: Before the intervention begins and 6 months after the intervention begins. Method of measurement: X8 medison ultrasound machine.
- Secondary Outcome Measures
Name Time Method Serum vitamin D levels. Timepoint: Before intervention and 6 months after intervention. Method of measurement: Radioimmunoassay.